Metabolomics-based discovery has an important role in disease diagnosis, discovery of drug, and treatment expansion. This tool is a novel biomarker that can provide a biochemical insight into disease stages and could estimate the activity of certain drugs; it can observe the preclinical and clinical cases, leading to discovery of more efficient methods for treatment approach. This review discussed the potential of metabolomics technology as a very important approach in disease diagnosis, therapy, as well as new drug discovery.
Ghanem, H., Kadry, M., Abdel-Megeed, R., & Abdel-Hamid, A. (2019). Metabolomics applications in disease diagnosis, treatment, and drug discovery. Egyptian Pharmaceutical Journal, 18(4), 290-295. doi: 10.4103/epj.epj_10_19
MLA
Hassan Z. Ghanem; Mai O. Kadry; Rehab M. Abdel-Megeed; Abdel-Hamid Z. Abdel-Hamid. "Metabolomics applications in disease diagnosis, treatment, and drug discovery", Egyptian Pharmaceutical Journal, 18, 4, 2019, 290-295. doi: 10.4103/epj.epj_10_19
HARVARD
Ghanem, H., Kadry, M., Abdel-Megeed, R., Abdel-Hamid, A. (2019). 'Metabolomics applications in disease diagnosis, treatment, and drug discovery', Egyptian Pharmaceutical Journal, 18(4), pp. 290-295. doi: 10.4103/epj.epj_10_19
VANCOUVER
Ghanem, H., Kadry, M., Abdel-Megeed, R., Abdel-Hamid, A. Metabolomics applications in disease diagnosis, treatment, and drug discovery. Egyptian Pharmaceutical Journal, 2019; 18(4): 290-295. doi: 10.4103/epj.epj_10_19
)
View on SCiNiTO